MOSAIC ENGINEERING LLC

Biotech

Programmable perfusion bioreactor platform for culturing human organoids and microphysiological systems

Grants
$377K
2 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase I · Programmable Microfluidic Perfusion Bioreactor for 3D Organoid Culture and Screening Applications$321,963
Federal grantDepartment of Health and Human Services · Phase I · Programmable Microfluidic Perfusion Bioreactor for 3D Organoid Culture and Screening Applications$55,000
Federal grant · SBIR/STTR

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1518Moonwalk Biosciences—$110M
1519DEGROME THERAPEUTICS, INC.——
1520Bell Biosystems, Inc.—$2.4M
1521MOSAIC ENGINEERING LLC——
1522SHY THERAPEUTICS, LLC——
1523Varda Space——
1524Phenzyme, Inc.——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.